pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Sionna Therapeutics, Inc. ($SION) · news · pharmadog
← back to Sionna Therapeutics, Inc.
News mentioning $SION
109
stories
10h
Genmab details ovarian cancer data; Lilly's Jaypirca gets a label expansion
endpoints
3d
Bayer unpacks plans for $2.2B manufacturing site in Ohio
endpoints
11d
Senators grill FDA nominee Heidi Overton
endpoints
11d
Kyverna says long-term data bolster FDA submission for rare autoimmune CAR-T
endpoints
14d
Pentagon defends designating WuXi AppTec as Chinese military company
endpoints
14d
Novo offers low-dose CagriSema data as approval decision looms
endpoints
14d
Iambic signs AbbVie deal, releases next generation of Enchant model
endpoints
14d
ADARx targets $319M IPO as TRexBio, Retension join filing queue
endpoints
14d
Novo aims to diversify with new pipeline assets and bolt-on deals
endpoints
17d
China sets ambitious goals for global biopharma expansion in new five-year plan
endpoints
18d
Roche eyes label expansion for Lunsumio after confirmatory lymphoma trial win
endpoints
19d
Drugmakers cooperate with House probe of China trial sites
endpoints
19d
Skyhawk says its Huntington’s drug improved symptoms in extension to Phase 1/2 trial
endpoints
20d
FDA clears first generic radioligand drug; Sionna turns to layoffs
biopharma dive
20d
Sionna cuts nearly half of staff as it lines up second attempt at cystic fibrosis
endpoints
20d
Contineum, J&J's drug fails in mid-stage depression trial
endpoints
20d
Sionna lays off 46% of workforce in strategic shift after cystic fibrosis trial fail
fiercebiotech
21d
AstraZeneca’s next-gen SERD Etcamah disappoints in untreated advanced breast cancer
endpoints
26d
Encoded closes $275M Series F for Dravet syndrome drug
endpoints
27d
Current heads of CBER, CDER snag permanent jobs
endpoints
27d
Pharvaris' stock jumps on pivotal success in rare genetic disease
endpoints
27d
Sandoz unveils plan for biosimilar expansion and new $300M factory in Slovenia
endpoints
Sep 3, 26
AbbVie claims Phase 3 win for multiple myeloma drug etentamig
endpoints
Sep 1, 26
ARPA-H awards $125M for manufacturing custom RNA therapies on demand
endpoints
Aug 31, 26
Trump announces nine new MFN drug pricing deals
endpoints
Aug 25, 26
J&J’s Imaavy wins label expansion; Two approvals in Japan
endpoints
Aug 25, 26
FDA approves Jazz's Ziihera in frontline gastric cancer
endpoints
Aug 24, 26
FDA delays Capricor's deramiocel PDUFA date to review new data
endpoints
Aug 20, 26
Epic's AI push overlaps with health tech startups
endpoints
Aug 19, 26
FDA pick Heidi Overton has been critical of vaccine requirements, abortion pills
endpoints
← prev
page 1 of 4
next →
